Skip to main content

Emerzene Inc

Dublin, Ireland

We use patented CRISPR technology to produce non-addictive opiates for pain management in collaboration with Merck Pharmaceuticals Germany

$5.3M raised
Dec 2021
Pre-Seed

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Emerzene Inc

How much funding has Emerzene Inc raised?
Emerzene Inc has raised $5.3M in total funding. The most recent round was Pre-Seed. The last funding was announced in December 2021.
Where is Emerzene Inc headquartered?
Emerzene Inc is headquartered in Dublin, Ireland.
What does Emerzene Inc do?
We use patented CRISPR technology to produce non-addictive opiates for pain management in collaboration with Merck Pharmaceuticals Germany
What stage is Emerzene Inc at?
Emerzene Inc is at the Pre-Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Emerzene Inc — Funding & Investors." VCBacked, December 24, 2021, https://www.vcbacked.co/company/emerzene-inc. Accessed July 2, 2026.
APA
VCBacked. (2021). Emerzene Inc — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/emerzene-inc
Wikipedia (cite web)
{{cite web |title=Emerzene Inc — Funding & Investors |url=https://www.vcbacked.co/company/emerzene-inc |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .